miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer stem cells (CSCs) are implicated in osteosarcoma pathogenesis and progression.
• Investigating the role of miR-335 in osteosarcoma stem cells is crucial for understanding disease mechanisms.

Purpose of the Study:

• To determine the role of miR-335 in osteosarcoma stem cells.
• To elucidate the regulatory mechanism of miR-335 on osteosarcoma stemness and chemosensitivity.

Main Methods:

• Screening of osteosarcoma stem cells using tumor spheroid culture and flow cytometry.
• Quantitative PCR to assess miR-335 expression; Transwell and transplantation assays for invasion and tumor formation.
• Western Blot and luciferase assays to investigate POU5F1 regulation by miR-335.

Main Results:

• miR-335 expression was lower in osteosarcoma stem cells compared to differentiated cells.
• miR-335 downregulation promoted stem cell properties and invasion; POU5F1 was identified as a target of miR-335.
• miR-335 restoration sensitized tumors to chemotherapy, while its inhibition induced chemoresistance.

Conclusions:

• miR-335 negatively regulates osteosarcoma stem cell properties by targeting POU5F1.
• miR-335 can be targeted to enhance the efficacy of traditional chemotherapeutic agents against osteosarcoma.